Since the outbreak of COVID-19 at the end of 2019, it has spread all over the world. Up to now, more than 190 million confirmed cases of COVID-19 have been reported worldwide, and more than 4.11 million patients have died, causing great disasters.
AB Science and the University of Chicago (UC) have signed an exclusive licensing agreement to carry out research on Covid-19 prevention and treatment with the former’s oral drug, masitinib and other drugs.